Bowel Dysfunction and HoLEP Outcomes
Launched by NORTHWESTERN UNIVERSITY · Nov 12, 2024
Trial Information
Current as of November 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into how bowel problems might affect the recovery of men who are undergoing a specific prostate surgery called holmium laser enucleation of the prostate (HoLEP). This surgery is often performed to help relieve lower urinary tract symptoms caused by an enlarged prostate, a common issue for older men. The researchers want to see if men who report more severe bowel issues before the surgery experience more discomfort and take longer to regain urinary control afterward. To gather information, they will use questionnaires that ask about bowel function and any related symptoms.
To participate in this study, men aged 18 to 89 who are scheduled for HoLEP and can fill out questionnaires are welcome to join. However, those with certain conditions, like having had specific bowel surgeries or known nerve issues affecting bowel control, will not be eligible. Participants can expect to complete questionnaires before, during, and after their surgery, helping researchers understand the link between bowel health and recovery from this type of prostate procedure. This information could ultimately improve care for future patients facing similar surgeries.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Males18-89 undergoing HoLEP
- • Able to read, understand, and complete patient questionnaires
- • Willing to sign the informed consent form
- Exclusion Criteria:
- • Patients with bowel diversion (colostomy, ileostomy)
- • Patients with known neurogenic bowel
- • Patients having concurrent ureteroscopy+/-laser lithotripsy, percutaneous nephrolithotomy, or non-urologic surgery at time of HoLEP
- • Anticipated need for perineal urethrostomy at time of HoLEP
- • Prior pelvic radiation or patients with history of bladder cancer with or without Bacillus Calmette-Guerin (BCG) therapy
- • Patients who lack decisional capacity
About Northwestern University
Northwestern University is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a robust infrastructure that supports interdisciplinary collaboration, Northwestern leverages its expertise in various fields, including medicine, engineering, and social sciences, to drive groundbreaking studies. The university is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring that all clinical trials are conducted with the utmost integrity and focus on participant safety. Through its Clinical Trials Office, Northwestern aims to translate scientific discoveries into effective therapies, ultimately enhancing health outcomes and contributing to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported